Aviara Pharmaceuticals, Inc., is a development-stage biopharmaceutical company focused on small-molecule pharmaceuticals that enhance the effectiveness of cell therapies and treat inflammatory diseases. Aviara is developing a portfolio of first-in-class and best-in-class small-molecule integrin antagonists directed against targets involved in the modulation of cell therapies and inflammatory diseases, such as hematopoietic stem cell mobilization, minimal residual disease in cancer, cardiac stem cell transplant, dry eye disease, and inflammatory bowel disease.
View Top Employees from Encysive Pharmaceuticals| Website | http://www.aviarapharma.com |
| Revenue | $942000 |
| Employees | 18 (16 on RocketReach) |
| Founded | 2010 |
| Address | 3331 Green Tree Park, Houston, Texas 77007, US |
| Phone | (646) 513-3125 |
| Industry | Pharmaceuticals, Drug Manufacturing & Research, Healthcare |
| Web Rank | 20 Million |
| Keywords | Aviara Pharmaceuticals, Ava4746 |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Encysive Pharmaceuticals employee's phone or email?
Encysive Pharmaceuticals Questions
The Encysive Pharmaceuticals annual revenue was $942000 in 2023.
Ajay Rege is the Director of Drug Development of Encysive Pharmaceuticals.
16 people are employed at Encysive Pharmaceuticals.
Encysive Pharmaceuticals is based in Houston, Texas.
The NAICS codes for Encysive Pharmaceuticals are [32, 325, 32541, 3254].
The SIC codes for Encysive Pharmaceuticals are [28, 283].
Top Encysive Pharmaceuticals Employees
-
34
-
35+
-
22
-
11
-
21
-
33
-
12
-
15+
Related Companies
